4.7 Article

Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis

期刊

GELS
卷 9, 期 5, 页码 -

出版社

MDPI
DOI: 10.3390/gels9050415

关键词

ketorolac; gel; hydrogels; alginate; sialolithiasis; mucosa; inflammation

向作者/读者索取更多资源

Sialolithiasis primarily affects the oral salivary glands due to obstruction from small stones, hindering saliva secretion. To ensure patient comfort, treatment and pain control are crucial in managing this condition. A ketorolac calcium cross-linked alginate hydrogel was developed and applied in the buccal cavity, showing desirable physicochemical properties and high drug concentrations to alleviate pain. The formulation was found suitable for oral application based on ex vivo drug release studies.
Sialolithiasis mainly affects the oral salivary glands due to the presence of small stones that obstruct the secretion of saliva. The treatment and control of pain and inflammation during the course of this pathology is essential to guarantee the patient's comfort. For this reason, a ketorolac calcium cross-linked alginate hydrogel was developed, and it was then applied in the area of the buccal cavity. The formulation was characterized (swelling and degradation profile, extrusion, extensibility, surface morphology, viscosity, and drug release). The drug release was studied ex vivo in static Franz cells and with a dynamic ex vivo method under artificial saliva continuous flow. The product exhibits adequate physicochemical properties considering the intended purpose, and the drug concentrations retained in the mucosa were high enough to deliver a therapeutic local concentration able to reduce the pain associated with the patient's conditions. The results confirmed the suitability of the formulation for application in the mouth.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据